MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 134 filers reported holding MACROGENICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,722 | -77.9% | 14,318 | -66.1% | 0.00% | – |
Q1 2023 | $302,495 | +45.5% | 42,189 | +36.2% | 0.00% | – |
Q4 2022 | $207,862 | +2.4% | 30,978 | -55.1% | 0.00% | – |
Q2 2022 | $203,000 | -72.8% | 68,996 | +48.4% | 0.00% | – |
Q4 2021 | $746,000 | -17.4% | 46,495 | +7.7% | 0.00% | – |
Q3 2021 | $903,000 | -36.8% | 43,157 | -18.9% | 0.00% | – |
Q2 2021 | $1,428,000 | -48.2% | 53,225 | -38.5% | 0.00% | – |
Q1 2021 | $2,756,000 | +159.3% | 86,529 | +86.0% | 0.00% | – |
Q4 2020 | $1,063,000 | +2.2% | 46,516 | +12.7% | 0.00% | – |
Q3 2020 | $1,040,000 | +55.9% | 41,287 | +72.9% | 0.00% | – |
Q2 2020 | $667,000 | +350.7% | 23,879 | +76.1% | 0.00% | – |
Q4 2019 | $148,000 | +13.8% | 13,557 | +33.6% | 0.00% | – |
Q3 2019 | $130,000 | -68.3% | 10,151 | -55.5% | 0.00% | -100.0% |
Q1 2019 | $410,000 | +0.7% | 22,787 | +41.0% | 0.00% | 0.0% |
Q1 2018 | $407,000 | +46.9% | 16,157 | +26.7% | 0.00% | -75.0% |
Q2 2014 | $277,000 | – | 12,754 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 2,115,000 | $37,034,000 | 8.81% |
INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $18,811,000 | 4.45% |
DAFNA Capital Management LLC | 119,200 | $2,087,000 | 1.49% |
BB BIOTECH AG | 2,350,112 | $41,150,000 | 1.26% |
TIGER MANAGEMENT L.L.C. | 239,667 | $4,197,000 | 0.82% |
Hood River Capital Management LLC | 576,193 | $10,089,000 | 0.70% |
Bellevue Group AG | 316,418 | $5,540,000 | 0.66% |
Rhenman & Partners Asset Management AB | 175,000 | $3,064,000 | 0.44% |
First Light Asset Management, LLC | 61,538 | $1,078,000 | 0.36% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 54,000 | $945,000 | 0.36% |